Presenters:
Alan Moore
Chief Strategy Officer
The Discovery Labs
Christopher Murphy
Vice President and General Manager, Viral Vector Services
Thermo Fisher Scientific, Pharma Services Group
Thomas VanCott, PhD
Global Head of Product Development, Cell & Gene Therapy
Catalent Cell & Gene Therapy
Moderators:
Rita Peters
Editorial Director
BioPharm International and Pharmaceutical Technology
Feliza Mirasol
Science Editor
BioPharm International and Pharmaceutical Technology
Presenters:
Alberto Santagostino
Senior Vice President and Head of Cell and Gene Therapies
Lonza Pharma and Biotech
Amy DuRoss
Co-Founder and CEO
Vineti
Mark Sawicki
Chief Commercial Officer
Cryoport
Moderator:
Agnes Shanley
Senior Editor
BioPharm International and Pharmaceutical Technology
Presenters:
Jason S. Collins
AIA, Director, Process Architecture
IPS
Curt Firestine
Mechanical Engineer
CRB
Moderator:
Rita Peters
Editorial Director
Pharmaceutical Technology
Jennifer Markarian
Manufacturing Editor
Pharmaceutical Technology
Mary Blenn, Vice-President, Global Supply Chain, Cytiva
Lisia Marina Scholz Dias, Lead Application Engineer, Applied Materials
Steve Goldman, Head of Steve Goldman Associates, A Risk Management and Business Continuity Consultancy
David Light, CEO of Valisure
Ron Najafi, CEO of Emery Pharma
Susan Schniepp, A Distinguished Fellow for Regulatory Compliance Associates
Angelo Stracquatanio, CEO, apprentice.io
Japp Venema, CSO, USP
Efficient manufacturing of biopharmaceutical drugs such as ADCs is challenging with respect to low costs & high drug efficiency. Application of a recently developed IEX resin for downstream purification of ADCs enabled an efficient DAR species separation.
Speakers:
Romas Skudas - Lab Head – Process Solutions Chromatography R&D, MilliporeSigma
Annika Holzgreve - Applications Engineer Process Solutions Chromatography R&D, MilliporeSigma
Developing vaccines and manufacturing large doses in an emergency is often constrained by existing platforms and facility set ups. Vaccine manufacturing need to evolve to tackle future global health challenges.
Speaker:
Anissa Boumlic-Courtade, Ph.D., Head of Global Vaccine & Plasma Segments – MilliporeSigma
Plasmid DNA presents unique manufacturing challenges. This webinar presents significant process understanding and scalable solutions for pDNA Purification from harvest to bulk filtration.
Speaker:
Youness Cherradi, Senior Process Development Scientist, MilliporeSigma
This webinar will focus on the potential of mRNA therapies and on the manufacturing process associated challenges and solutions.
Speakers:
Manuel Brantner, MSc, Associate Director Vaccines & Plasma Segment, MilliporeSigma
Nargisse El-Hajjami, PhD, Associate Director for Cell and Gene Therapy, MilliporeSigma
Controlled Environment Agriculture is one of the fastest growing segments in food markets around the world. As the demand for locally grown and organic products continues to rise, the demand is being met by today’s modern greenhouses, vertical, and container farms. Advancements in technology and techniques available today allow growers to produce more, with greater consistency, while using less energy and resources.
You’ll come away understanding:
This webinar is 45 minutes long and includes a Q&A session.
Speakers, moderators, etc.:
Justin Walsh is a Business Development Engineer at Vaisala. He has been working with electro-chemical and industrial measurement technologies for over 16 years, ensuring product quality, measurement accuracy and environmental safety. His experience includes application support with Thermo, environmental consulting, emergency planning and response with the US EPA, and a degree in Environmental Engineering from the University of Miami.